Longitudinal assessment of genetic and epigenetic markers in progressive oligodendroglial tumors (OT)

被引：0
|
作者：
Lavon, I.
Zelikovitsh, B.
Zrihan, Daniel
Fellig, Y.
Soffer, D.
Siegall, T.
机构：
[1] Hadassah Hebrew Univ Hosp, Gaffin Ctr Nuero Oncol, Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel
[3] Hadassah Univ Hosp, Dept Pathol, IL-91120 Jerusalem, Israel
来源：
NEURO-ONCOLOGY | 2006年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：460 / 460
页数：1
相关论文
共 50 条
  • [41] Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy
    Sarangi, Sudhir Chandra
    Sopory, Pranav
    Reeta, K. H.
    NEUROLOGY INDIA, 2021, 69 (02) : 252 - 259
  • [42] Integration of genetic and epigenetic markers for risk stratification: opportunities and challenges
    Pashayan, Nora
    Reisel, Daniel
    Widschwendter, Martin
    PERSONALIZED MEDICINE, 2016, 13 (02) : 93 - 95
  • [43] GENETIC AND EPIGENETIC MARKERS OF OBESITY: LESSONS FROM INTERVENTION STUDIES
    Marti, A.
    ACTA PHYSIOLOGICA, 2014, 212 : 13 - 13
  • [44] Nutrigenomics: where are we with genetic and epigenetic markers for disposition and susceptibility?
    Kussmann, Martin
    Krause, Lutz
    Siffert, Winfried
    NUTRITION REVIEWS, 2010, 68 (11) : S38 - S47
  • [45] Genetic and epigenetic markers in colorectal cancer screening: recent advances
    Singh, Manish Pratap
    Rai, Sandhya
    Suyal, Shradha
    Singh, Sunil Kumar
    Singh, Nand Kumar
    Agarwal, Akash
    Srivastava, Sameer
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (07) : 665 - 685
  • [46] An Integrative Approach for Analyzing the Interplay of Genetic and Epigenetic Changes in Tumors
    Muradyan, Artur
    Boldt, Vivien
    Steininger, Anne
    Stabentheiner, Stephanie
    Tebel, Katrin
    Kreutzberger, Juergen
    Mueller, Ines
    Madle, Hannelore
    Popper, Helmut H.
    Ullmann, Reinhard
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (10) : 1557 - 1561
  • [47] Hedgehog Signaling Pathway as Genetic and Epigenetic Target in Ovarian Tumors
    Levanat, Sonja
    Sabol, Maja
    Musani, Vesna
    Ozretic, Petar
    Trnski, Diana
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (01) : 73 - 94
  • [48] Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
    Chan, Aden Ka-Yin
    Pang, Jesse Chung-Sean
    Chung, Nellie Yuk-Fei
    Li, Kay Ka-Wai
    Poon, Wai Sang
    Chan, Danny Tat-Ming
    Shi, Zhifeng
    Chen, Liang
    Zhou, Liangfu
    Ng, Ho-Keung
    MODERN PATHOLOGY, 2014, 27 (03) : 332 - 342
  • [49] LOSS OF CIC AND FUBP1 EXPRESSIONS ARE POTENTIAL MARKERS OF SHORTER TIME TO RECURRENCE IN OLIGODENDROGLIAL TUMORS
    Chan, Aden Ka-Yin
    Pang, Jesse Chung-Sean
    Chung, Nellie Yuk-Fei
    Li, Kay Ka-Wai
    Poon, Wai Sang
    Chan, Danny Tat-Ming
    Wang, Yin
    Ng, Ho-and Keung
    NEURO-ONCOLOGY, 2013, 15 : 138 - 138
  • [50] Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors
    Sankar, Tejas
    Moore, Nina Z.
    Johnson, Joshua
    Ashby, Lynn S.
    Scheck, Adrienne C.
    Shapiro, William R.
    Smith, Kris A.
    Spetzler, Robert F.
    Preul, Mark C.
    JOURNAL OF NEUROSURGERY, 2012, 116 (06) : 1172 - 1181
12345